A classification model for G-to-A hypermutation in hepatitis B virus ultra-deep pyrosequencing reads

Bioinformatics

Volumn 26, Issue 23, 2010, Pages 2929-2932

  Reuman, Elizabeth C ^a   Margeridon Thermet, Severine ^a   Caudill, Harrison B ^a   Liu, Tommy ^a   Borroto Esoda, Katyna ^b   Svarovskaia, Evguenia S ^b   Holmes, Susan P ^c   Shafer, Robert W ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GILEAD SCIENCES   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VIRUS;

ADENINE; GUANINE;

ALGORITHM; ANTIVIRAL RESISTANCE; ARTICLE; CLASSIFICATION; GENETICS; HEPATITIS B; HEPATITIS B VIRUS; HIGH THROUGHPUT NUCLEOTIDE SEQUENCING; HUMAN; METHODOLOGY; MUTATION; NUCLEOTIDE SEQUENCE; STATISTICAL MODEL; VIROLOGY;

ADENINE; ALGORITHMS; CLASSIFICATION; DNA MUTATIONAL ANALYSIS; DRUG RESISTANCE, VIRAL; GUANINE; HEPATITIS B; HEPATITIS B VIRUS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MODELS, STATISTICAL; MUTATION;

EID: 78449313051     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/btq570     Document Type: Article

References (21)

1. Cullen, B.R. (2006) Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors. J. Virol., 80, 1067-1076.
2. Dempster, A.P. et al. (1977) Maximum likelihood from incomplete data via the EM algorithm. J. R. Stat. Soc. Series B Methodol., 39, 1-38.
3. Fares, M.A. and Holmes, E.C. (2002) A revised evolutionary history of hepatitis B virus (HBV). J. Mol. Evol., 54, 807-814.
4. Gifford, R.J. et al. (2008) Sequence editing by Apolipoprotein B RNA-editing catalytic component and epidemiological surveillance of transmitted HIV-1 drug resistance. AIDS, 22, 717-725.
5. Henry, M. et al. (2009) Genetic editing of HBVDNAby monodomain humanAPOBEC3 cytidine deaminases and the recombinant nature of APOBEC3G. PLoS ONE, 4, e4277.
6. Kijak, G.H. et al. (2007) HyperPack: a software package for the study of levels, contexts, and patterns of APOBEC-mediated hypermutation in HIV. AIDS Res. Hum. Retroviruses, 23, 554-557.
7. Kock, J. and Blum, H.E. (2008) Hypermutation of hepatitis B virus genomes by APOBEC3G, APOBEC3C and APOBEC3H. J. Gen. Virol., 89, 1184-1191.
8. Locarnini, S. and Warner, N. (2007) Major causes of antiviral drug resistance and implications for treatment of hepatitis B virus monoinfection and coinfection with HIV. Antivir. Ther., 12(Suppl. 3), H15-H23.
9. Lok, A.S. et al. (2007) Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management. Hepatology, 46, 254-265.
10. Margeridon-Thermet, S. et al. (2009) Ultra-deep pyrosequencing of hepatitis B virus quasispecies from nucleoside and nucleotide reverse-transcriptase inhibitor (NRTI)-treated patients and NRTI-naive patients. J. Infect. Dis., 199, 1275-1285.
11. Noguchi, C. et al. (2005) G to A hypermutation of hepatitis B virus. Hepatology, 41, 626-633.
12. Preikschat, P. et al. (1999) Hepatitis B virus genomes from long-term immunosuppressed virus carriers are modified by specific mutations in several regions. J. Gen. Virol., 80 (Pt 10), 2685-2691.
13. Rice, J.A. (2007). Mathematical Statistics and Data Analysis, 3rd edn. Thomson Brooks/Cole, p. 469.
14. Rose, P.P. and Korber, B.T. (2000) Detecting hypermutations in viral sequences with an emphasis on G -> A hypermutation. Bioinformatics, 16, 400-401.
15. Rozanov, M. et al. (2004)Aweb-based genotyping resource for viral sequences. Nucleic Acids Res., 32, W654-W659.
16. Sheehy, A.M. et al. (2002) Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature, 418, 646-650.
17. Solmone, M. et al. (2009) Use of massively parallel ultradeep pyrosequencing to characterize the genetic diversity of hepatitis B virus in drug-resistant and drugnaive patients and to detect minor variants in reverse transcriptase and hepatitis B S antigen. J. Virol., 83, 1718-1726.
18. Suspène, R. et al. (2005) Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo. Proc. Natl Acad. Sci. USA, [102] 8321-8326.
19. Varghese, V. et al. (2010) Nucleic acid template and the risk of a PCR-Induced HIV-1 drug resistance mutation. PLoS ONE, 5, e10992.
20. Vrancken, B. et al. (2010) Covering all bases in HIV research: unveiling a hidden world of viral evolution. AIDS Rev., 12, 89-102.
21. Wang, C. et al. (2007) Characterization of mutation spectra with ultra-deep pyrosequencing: application to HIV-1 drug resistance. Genome Res., 17, 1195-1201.